Article
type: Class

Document
type: Class

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
type: Entity
type: Document
type: Thing
type: Academic Article
type: Generically Dependent Continuant
most specific type: Academic Article
type: Article
type: Continuant
type: Information Content Entity
related by: 5734254

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T09:28:48
publisher: Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
type: Document
label: RDF description of Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study - http://irises.unisr.it/resource/item/104155

5734254
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Generically Dependent Continuant
type: Class